[RHBBANK] QoQ Annualized Quarter Result on 31-Mar-2022 [#1]

Announcement Date
30-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -8.3%
YoY- -7.69%
View:
Show?
Annualized Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 13,278,708 12,438,014 11,687,398 11,431,120 11,748,749 11,809,286 11,661,054 9.02%
PBT 4,170,784 3,931,522 3,818,704 3,562,200 3,528,753 3,474,928 3,554,792 11.20%
Tax -1,458,763 -1,347,416 -1,345,034 -1,157,192 -905,621 -819,100 -846,612 43.58%
NP 2,712,021 2,584,106 2,473,670 2,405,008 2,623,132 2,655,828 2,708,180 0.09%
-
NP to SH 2,707,688 2,580,764 2,470,190 2,401,068 2,618,388 2,649,630 2,703,262 0.10%
-
Tax Rate 34.98% 34.27% 35.22% 32.49% 25.66% 23.57% 23.82% -
Total Cost 10,566,687 9,853,908 9,213,728 9,026,112 9,125,617 9,153,458 8,952,874 11.64%
-
Net Worth 28,619,247 28,044,431 27,051,673 28,067,858 27,806,567 27,827,307 27,520,536 2.63%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 1,693,271 842,415 1,246,295 - 1,645,821 812,784 1,203,013 25.51%
Div Payout % 62.54% 32.64% 50.45% - 62.86% 30.68% 44.50% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 28,619,247 28,044,431 27,051,673 28,067,858 27,806,567 27,827,307 27,520,536 2.63%
NOSH 4,247,373 4,212,077 4,212,077 4,142,918 4,142,918 4,068,360 4,010,045 3.89%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 20.42% 20.78% 21.17% 21.04% 22.33% 22.49% 23.22% -
ROE 9.46% 9.20% 9.13% 8.55% 9.42% 9.52% 9.82% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 313.68 295.29 281.33 275.92 285.54 290.59 290.80 5.16%
EPS 64.69 61.89 59.54 57.96 64.65 65.77 67.42 -2.71%
DPS 40.00 20.00 30.00 0.00 40.00 20.00 30.00 21.07%
NAPS 6.7607 6.6581 6.5117 6.7749 6.7581 6.8474 6.8629 -0.99%
Adjusted Per Share Value based on latest NOSH - 4,142,918
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 304.59 285.31 268.09 262.21 269.50 270.89 267.49 9.01%
EPS 62.11 59.20 56.66 55.08 60.06 60.78 62.01 0.10%
DPS 38.84 19.32 28.59 0.00 37.75 18.64 27.60 25.49%
NAPS 6.5648 6.433 6.2052 6.4383 6.3784 6.3832 6.3128 2.63%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 5.79 5.56 5.73 5.96 5.37 5.46 5.40 -
P/RPS 1.85 1.88 2.04 2.16 1.88 1.88 1.86 -0.35%
P/EPS 9.05 9.07 9.64 10.28 8.44 8.37 8.01 8.45%
EY 11.05 11.02 10.38 9.72 11.85 11.94 12.48 -7.77%
DY 6.91 3.60 5.24 0.00 7.45 3.66 5.56 15.54%
P/NAPS 0.86 0.84 0.88 0.88 0.79 0.80 0.79 5.80%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 27/02/23 29/11/22 29/08/22 30/05/22 28/02/22 30/11/21 27/08/21 -
Price 5.60 5.67 5.81 5.91 5.80 5.31 5.51 -
P/RPS 1.79 1.92 2.07 2.14 2.03 1.83 1.89 -3.54%
P/EPS 8.75 9.25 9.77 10.20 9.11 8.14 8.17 4.66%
EY 11.42 10.81 10.23 9.81 10.97 12.28 12.23 -4.45%
DY 7.14 3.53 5.16 0.00 6.90 3.77 5.44 19.81%
P/NAPS 0.83 0.85 0.89 0.87 0.86 0.78 0.80 2.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment